Clinical collaborations

Improving human health requires close collaboration between research and clinical care

JAX partners with researchers, clinicians, healthcare organizations, industry partners, and patient communities to advance discovery and accelerate the translation of research into improved health outcomes.

Our approach

Connect research with clinical practice
Share genomic expertise and advanced technologies
Build collaborative networks that accelerate discovery
Improve access to precision medicine

Featured collaborations

Maine Cancer Genomic Initiative

The Maine Cancer Genomics Initiative (MCGI) is an alliance of Maine oncology providers led by The Jackson Laboratory with funding from the Harold Alfond™ Foundation. Its primary goal is to reduce disparities in access to advanced technologies for cancer care and precision medicine.

Advanced Precision Medicine Laboratory

The JAX Advanced Precision Medicine Laboratory (APML) provides precise genomic solutions to enhance personalized care in disease treatment.

JAX-NYSCF Collaborative and GSK announce collaboration

Collaboration advances next-generation, human-relevant research tools to accelerate the development of treatments for Alzheimer’s disease and other neurodegenerative conditions

RDTC Collaborations

With more than 60 successful collaborations, JAX’s Rare Disease Translational Center (RDTC) is a vital research hub for the rare disease community.